Q4 2025 Holdings
Filed 2026-02-17 | 145 holdings | $580.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc(VRTX)Call | COM | 92532F100 | $40.0M | 88,300 | 6.9% |
| Spdr Series Trust(XBI)Put | STATE STREET SPD | 78464A870 | $30.5M | 250,000 | 5.3% |
| Praxis Precision Medicines I(PRAX)Put | COM NEW | 74006W207 | $29.7M | 100,600 | 5.1% |
| Viking Therapeutics Inc(VKTX)Call | COM | 92686J106 | $24.2M | 688,900 | 4.2% |
| Avidity Biosciences Inc(RNA)Call | COM | 05370A108 | $23.7M | 328,000 | 4.1% |
| Invesco QQQ TR(QQQ)Put | UNIT SER 1 | 46090E103 | $18.4M | 30,000 | 3.2% |
| Jazz Pharmaceuticals PLC(JAZZ)Call | SHS USD | G50871105 | $17.9M | 105,300 | 3.1% |
| Apogee Therapeutics Inc(APGE)Call | COM | 03770N101 | $15.9M | 211,100 | 2.7% |
| Bridgebio Pharma Inc(BBIO)Put | COM | 10806X102 | $15.3M | 200,000 | 2.6% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $14.0M | 345,880 | 2.4% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $13.8M | 66,444 | 2.4% |
| Structure Therapeutics Inc(GPCR)Call | SPONSORED ADS | 86366E106 | $13.3M | 191,700 | 2.3% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $11.9M | 336,849 | 2.0% |
| Viking Therapeutics Inc(VKTX)Put | COM | 92686J106 | $11.1M | 316,700 | 1.9% |
| Bridgebio Pharma Inc(BBIO)Call | COM | 10806X102 | $10.7M | 139,600 | 1.8% |
| Johnson & Johnson(JNJ)Call | COM | 478160104 | $10.3M | 50,000 | 1.8% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $10.2M | 75,644 | 1.8% |
| Incyte Corp(INCY)Put | COM | 45337C102 | $9.9M | 100,000 | 1.7% |
| Insmed Inc(INSM)Call | COM PAR $.01 | 457669307 | $9.2M | 52,800 | 1.6% |
| Capricor Therapeutics Inc(CAPR)Call | COM NEW | 14070B309 | $9.0M | 312,300 | 1.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $8.7M | 146,361 | 1.5% |
| Ionis Pharmaceuticals Inc(IONS)Call | COM | 462222100 | $8.4M | 106,200 | 1.4% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $8.0M | 10,300 | 1.4% |
| Indivior PLC(INDV)Call | ORD | G4766E116 | $7.9M | 220,300 | 1.4% |
| Uniqure NV(QURE)Put | SHS | N90064101 | $7.2M | 301,800 | 1.2% |
| Roivant Sciences LTD(ROIV)Put | SHS | G76279101 | $6.9M | 318,700 | 1.2% |
| Ocular Therapeutix Inc(OCUL)Call | COM | 67576A100 | $6.6M | 545,200 | 1.1% |
| Zymeworks Inc(ZYME)Call | COM | 98985Y108 | $6.3M | 240,600 | 1.1% |
| Crispr Therapeutics AG(CRSP)Call | NAMEN AKT | H17182108 | $5.9M | 112,700 | 1.0% |
| Capricor Therapeutics Inc(CAPR)Put | COM NEW | 14070B309 | $5.8M | 200,000 | 1.0% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $5.4M | 70,000 | 0.9% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $4.9M | 10,000 | 0.8% |
| Corcept Therapeutics Inc(CORT)Put | COM | 218352102 | $4.7M | 134,800 | 0.8% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $4.7M | 131,852 | 0.8% |
| Capricor Therapeutics Inc(CAPR) | COM NEW | 14070B309 | $4.6M | 158,075 | 0.8% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $4.5M | 10,000 | 0.8% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $4.2M | 53,354 | 0.7% |
| Regeneron Pharmaceuticals(REGN)Call | COM | 75886F107 | $3.9M | 5,000 | 0.7% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $3.7M | 123,283 | 0.6% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $3.6M | 271,164 | 0.6% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $3.4M | 97,445 | 0.6% |
| Mannkind Corp(MNKD)Call | COM NEW | 56400P706 | $3.1M | 552,300 | 0.5% |
| Recursion Pharmaceuticals in(RXRX)Call | CL A | 75629V104 | $3.0M | 741,900 | 0.5% |
| TG Therapeutics Inc(TGTX)Put | COM | 88322Q108 | $3.0M | 100,000 | 0.5% |
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $3.0M | 243,170 | 0.5% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $2.9M | 37,020 | 0.5% |
| Intellia Therapeutics Inc(NTLA)Put | COM | 45826J105 | $2.8M | 316,900 | 0.5% |
| Gossamer BIO Inc(GOSS)Call | COM | 38341P102 | $2.7M | 877,100 | 0.5% |
| Novo-Nordisk A S(NVO)Put | ADR | 670100205 | $2.7M | 53,100 | 0.5% |
| Arbutus Biopharma Corp(ABUS)Call | COM | 03879J100 | $2.6M | 548,600 | 0.5% |